کد مقاله کد نشریه سال انتشار مقاله انگلیسی ترجمه فارسی نسخه تمام متن
2659746 1140308 2016 9 صفحه PDF سفارش دهید دانلود کنید
عنوان انگلیسی مقاله ISI
Parkinson’s Disease: Update on Medication Management
ترجمه فارسی عنوان
بیماری پارکینسون: به روز رسانی در مدیریت دارو
کلمات کلیدی
کاربی؛ آگونیست های دوپامین. دیسکینزی؛ لوودوپا. بیماری پارکینسون
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی پزشکی و دندانپزشکی (عمومی)
چکیده انگلیسی


• Parkinson’s disease is reviewed to provide an understanding of the pharmacologic therapies used to treat motor and nonmotor symptoms.
• Levadopa and carbidopa are the gold standard of treatment; doses, side effects, and formulations are discussed.
• The different classes of medications used to treat Parkinson’s disease, and those used to mitigate side effects of treatment and Parkinsonism, are reviewed.
• An overview of deep brain stimulation is provided, which is often used in the advanced stages of the disease to decrease medication doses.

Parkinson's disease (PD) is a chronic and progressive neurodegenerative disorder. Its estimated prevalence is 1 million individuals in the United States, with approximately 60,000 people newly diagnosed in the US every year. The incidence and diagnosis of PD will increase in the next decades as our population ages. Nurse practitioners will need to be familiar with the presentation and progression and pharmacologic treatment of PD. This disease has a broad range of motor and nonmotor manifestations. The present article reviews medication treatment for both motor and nonmotor symptoms of PD.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: The Journal for Nurse Practitioners - Volume 12, Issue 3, March 2016, Pages e81–e89
نویسندگان
,